- Home
- DSS vs BFRI Comparison
DSS vs BFRI Comparison
Compare DSS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- BFRI
- Stock Information
- Founded
- DSS 1984
- BFRI 1997
- Country
- DSS United States
- BFRI United States
- Employees
- DSS N/A
- BFRI N/A
- Industry
- DSS Containers/Packaging
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- BFRI Health Care
- Exchange
- DSS Nasdaq
- BFRI Nasdaq
- Market Cap
- DSS 8.0M
- BFRI 7.5M
- IPO Year
- DSS N/A
- BFRI 2021
- Fundamental
- Price
- DSS $0.94
- BFRI $0.83
- Analyst Decision
- DSS
- BFRI Strong Buy
- Analyst Count
- DSS 0
- BFRI 1
- Target Price
- DSS N/A
- BFRI $7.00
- AVG Volume (30 Days)
- DSS 14.0K
- BFRI 67.6K
- Earning Date
- DSS 05-13-2025
- BFRI 05-14-2025
- Dividend Yield
- DSS N/A
- BFRI N/A
- EPS Growth
- DSS N/A
- BFRI N/A
- EPS
- DSS N/A
- BFRI N/A
- Revenue
- DSS $19,097,000.00
- BFRI $37,321,000.00
- Revenue This Year
- DSS N/A
- BFRI $18.57
- Revenue Next Year
- DSS N/A
- BFRI $20.17
- P/E Ratio
- DSS N/A
- BFRI N/A
- Revenue Growth
- DSS N/A
- BFRI 9.54
- 52 Week Low
- DSS $0.77
- BFRI $0.65
- 52 Week High
- DSS $1.94
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- DSS 50.52
- BFRI 48.00
- Support Level
- DSS $0.88
- BFRI $0.79
- Resistance Level
- DSS $1.00
- BFRI $0.87
- Average True Range (ATR)
- DSS 0.06
- BFRI 0.06
- MACD
- DSS 0.00
- BFRI 0.01
- Stochastic Oscillator
- DSS 55.56
- BFRI 80.79
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.